Johns Hopkins ABX Guide
Telithromycin
INDICATIONS
FDA
FDA
- Mild to moderate severe community-acquired pneumonia due to S. pneumoniae (including multi-drug resistant isolates), H. influenzae, M. catarrhalis, C. pneumoniae, or M. pneumoniae.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Sinusitis, acute (FDA indication withdrawn 2007 due to a low benefit vs. risk ratio)
- Chronic bronchitis, acute exacerbations (FDA indication withdrawn due to a low benefit vs. risk ratio)
- Pharyngitis
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 4, 2019
Citation
Dzintars, Kathryn, and Paul A Pham. "Telithromycin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540540/all/Telithromycin.
Dzintars K, Pham PA. Telithromycin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540540/all/Telithromycin. Accessed December 9, 2024.
Dzintars, K., & Pham, P. A. (2019). Telithromycin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540540/all/Telithromycin
Dzintars K, Pham PA. Telithromycin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2024 December 09]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540540/all/Telithromycin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Telithromycin
ID - 540540
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2019/01/04/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540540/all/Telithromycin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
